An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2012.0058 ◽

2013 ◽

Vol 23 (10) ◽

pp. 676-686 ◽

Author(s):

Justine M. Kent ◽

David Hough ◽

Jaskaran Singh ◽

Keith Karcher ◽

Gahan Pandina

Keyword(s):

Children And Adolescents ◽

Autistic Disorder ◽

Extension Study ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12607 ◽

2017 ◽

Vol 72 (2) ◽

pp. 84-94 ◽

Author(s):

Hironobu Ichikawa ◽

Michio Hiratani ◽

Akihiro Yasuhara ◽

Noa Tsujii ◽

Takashi Oshimo ◽

...

Keyword(s):

Children And Adolescents ◽

Autistic Disorder ◽

Safety And Efficacy ◽

Long Term Study ◽

Open Label Extension

Download Full-text

Five-year open-label extension study of safety and efficacy of etanercept in children and adolescents with moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.977 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB251

Keyword(s):

Children And Adolescents ◽

Plaque Psoriasis ◽

Extension Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis ◽

Open Label Extension

Download Full-text

Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2009.11.080 ◽

2010 ◽

Vol 62 (3) ◽

pp. AB11

Keyword(s):

Children And Adolescents ◽

Plaque Psoriasis ◽

Extension Study ◽

Etanercept Treatment ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

Effect of lurasidone on cognition in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2018.11.563 ◽

2019 ◽

Vol 29 ◽

pp. S367-S368

Author(s):

K.E. Burdick ◽

R. Goldman ◽

M. Tocco ◽

L. Deng ◽

A. Loebel

Keyword(s):

Children And Adolescents ◽

Interim Analysis ◽

Bipolar Depression ◽

Extension Study ◽

Open Label Extension

Download Full-text

Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study

The Journal of Allergy and Clinical Immunology In Practice ◽

10.1016/j.jaip.2021.07.050 ◽

2021 ◽

Author(s):

Gerald J. Gleich ◽

Florence Roufosse ◽

Geoffrey Chupp ◽

Stanislas Faguer ◽

Bastian Walz ◽

...

Keyword(s):

Hypereosinophilic Syndrome ◽

Extension Study ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756286418759315 ◽

2018 ◽

Vol 11 ◽

pp. 175628641875931 ◽

Author(s):

Miho Murata ◽

Masahito Mihara ◽

Kazuko Hasegawa ◽

Beomseok Jeon ◽

Chon-Haw Tsai ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extension Study ◽

Advanced Parkinson’S Disease ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

103. Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

Rheumatology ◽

10.1093/rheumatology/keu101.024 ◽

2014 ◽

Vol 53 (suppl_1) ◽

pp. i96-i96 ◽

Author(s):

Edward Keystone ◽

Robert Landewé ◽

Ronald van Vollenhoven ◽

Bernard Combe ◽

Vibeke Strand ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Extension Study ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Open Label Extension

Download Full-text

P036 LONG-TERM SAFETY AND EFFICACY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II)

Gastroenterology ◽

10.1053/j.gastro.2019.01.088 ◽

2019 ◽

Vol 156 (3) ◽

pp. S25-S26

Author(s):

Walter Reinisch ◽

William J. Sandborn ◽

Silvio Danese ◽

Xavier Hébuterne ◽

Bruce Salzberg ◽

...

Keyword(s):

Ulcerative Colitis ◽

Cell Adhesion ◽

Adhesion Molecule ◽

Cell Adhesion Molecule ◽

Extension Study ◽

Safety And Efficacy ◽

Open Label Extension ◽

Cell Adhesion Molecule 1

Download Full-text

Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30517-8 ◽

2021 ◽

Author(s):

Mark A Chilvers ◽

Jane C Davies ◽

Carlos Milla ◽

Simon Tian ◽

Zifei Han ◽

...

Keyword(s):

Cystic Fibrosis ◽

Extension Study ◽

Phase 3 ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

MP31-01 LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY

The Journal of Urology ◽

10.1016/j.juro.2017.02.955 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Scott MacDiarmid ◽

J.P. Nicandro ◽

Maria Cheng ◽

Steven Abrams ◽

Seymour Fein ◽

...

Keyword(s):

Extension Study ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text